| Entry |
|
|---|
| Name |
Pyrazinamide (JP16/USP/INN);
Pyrazinamide (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C5H5N3O
|
|---|
| Exact mass |
123.0433
|
|---|
| Mol weight |
123.1127
|
|---|
| Structure |
     |
|---|
| Activity |
Antibacterial [tuberculostatic] [DS: H00342]
|
|---|
| Remark |
Same as: Therapeutic category: ATC code: |
|---|
| Comment |
Pyrazinamide is a prodrug of pyrazinoic acid (POA) [CPD: C19915]
|
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
622 Tuberculosis preparations
6223 Pyrazinamides
D00144 Pyrazinamide (JP16/USP/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AK Other drugs for treatment of tuberculosis
J04AK01 Pyrazinamide
D00144 Pyrazinamide (JP16/USP/INN)
USP drug classification [BR:br08302]
Antimycobacterials
Antituberculars
Pyrazinamide
D00144 Pyrazinamide (JP16/USP/INN)
 |
|---|
| Other DBs |
CAS: 98-96-4 PubChem: DrugBank: PDB-CCD: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 9
1 C8y C 16.5851 -14.5401
2 C8x C 16.5851 -15.9475
3 N5x N 15.3632 -13.8427
4 C5a C 17.7880 -13.8427
5 N5x N 15.3632 -16.6577
6 C8x C 14.1604 -14.5401
7 N1a N 18.9971 -14.5336
8 O5a O 17.7880 -12.5880
9 C8x C 14.1604 -15.9475
BOND 9
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 4 8 2
8 5 9 2
9 6 9 1
|
|---|
